4
Changes in Ownership
Aldeyra Therapeutics, Inc. Filed Acc 0000899243-20-016185
Options or other derivatives
- Director acquired 30,355 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Bronstein Ben Director | 2020-06-09 | Grant or award · Stock Option (Right to Buy) | +26,503 | 26,503 | D | ||
| Bronstein Ben Director | 2020-06-09 | Grant or award · Stock Option (Right to Buy) | +2,311 | 2,311 | D | ||
| Bronstein Ben Director | 2020-06-09 | Grant or award · Stock Option (Right to Buy) | +1,541 | 1,541 | D | ||
Loading xslF345X03/doc4.xml…